As we have reported, the LILRB4 blocking antibody h128-3 inhibits monocytic AML development by multiple mechanisms, including reversal of LILRB4-mediated AML tissue infiltration and local T-cell suppression [5]. This evidence concerns the gene LILRB4 and acute myeloid leukemia.